To further investigate the role of integrin α10 as a target in GBM, we investigated the effect of anti-α10-SAP in an orthotopic xenograft model established in nonobese diabetic/severe combined immunodeficiency (NOD-SCID) mice using the GBM U3054MG cells. The gene discussed is IGKV6D-21; the disease is glioblastoma.